ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Total Non-current Liabilities
All obligations due after more than one year.
No reported Total Non-current Liabilities figures are available to summarize.
Total Non-current Liabilities history
Currency unavailable · from the balance sheet
No Total Non-current Liabilities data reported for this period type.
Total Non-current Liabilities vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $181.74M USD | -2.8% | +120.0% | 61.7% | |
| Mar 2026 | $126.66M USD | -8.6% | +2.5% | 51.8% | |
| Mar 2026 | $55.26M USD | -80.2% | -4.4% | 48.0% | |
| Mar 2026 | $36.35M USD | — | — | 12.4% | |
| Mar 2026 | €26.41M EUR | -37.4% | -28.2% | 26.6% | |
| Mar 2026 | $21.98M USD | -24.6% | -47.7% | 3.8% | |
| Mar 2026 | $19.68M USD | -59.5% | -26.8% | 8.0% | |
| Mar 2026 | $7.59M USD | -37.4% | -41.2% | 1.7% | |
| Mar 2026 | $394K USD | -35.7% | -4.0% | 0.2% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -36.6% | -15.6% | 12.4% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.